Philadelphia Court of Common Pleas Judge Arnold New is taking a different tack in trying cases in the Xarelto mass tort program.
Cases over the blood thinner will be tried using the bellwether selection system, according to an order issued by New last week. Mass tort programs that are currently conducting trials, including the Risperdal and the pelvic mesh litigations, have been using the first-in, first-out method for selecting what cases will be first to hit trial.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
